This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aprogen Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Kyung Soo Inn: Innovator in Anthrax Toxin Neutralization
Introduction
Kyung Soo Inn is a prominent inventor based in Taejon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on creating solutions for serious health threats, including anthrax toxin.
Latest Patents
Kyung Soo Inn holds a patent for a monoclonal antibody that is specific to anthrax toxin. This innovative antibody exhibits a very high affinity for the toxin and demonstrates potent toxin-neutralizing activity. The patent also includes a composition for neutralizing anthrax toxin that comprises the antibody, as well as a kit designed for detecting anthrax toxin.
Career Highlights
Kyung Soo Inn is associated with Aprogen Inc., a company that specializes in biopharmaceuticals. His work at Aprogen Inc. has allowed him to collaborate with other talented researchers in the field. His contributions have been instrumental in advancing the understanding and treatment of anthrax-related health issues.
Collaborations
Some of his notable coworkers include Se Yeon Kim and Sang Yoon Lee. Their collaborative efforts have further enhanced the research and development of effective solutions against anthrax toxin.
Conclusion
Kyung Soo Inn's innovative work in developing monoclonal antibodies for anthrax toxin neutralization showcases his dedication to addressing critical health challenges. His contributions to biotechnology continue to have a significant impact on public health and safety.